Proteasome inhibitors in non-Hodgkin's lymphoma Journal Article


Author: Zelenetz, A.
Article Title: Proteasome inhibitors in non-Hodgkin's lymphoma
Abstract: Proteasome inhibition is emerging as a potential treatment strategy for a broadening variety of tumors, including NHL. This article gives background information as well as a review of recent study results. © Journal of the National Comprehensive Cancer Network.
Keywords: cancer chemotherapy; treatment response; clinical trial; conference paper; bortezomib; proteasome; proteasome inhibitor; mantle cell lymphoma; multiple myeloma; sensory neuropathy; boronic acids; protease inhibitors; pyrazines; thrombocytopenia; asthenia; lymphocytopenia; cancer inhibition; nonhodgkin lymphoma; non-hodgkin's lymphoma; lymphoma, non-hodgkin; follicular lymphoma; boronic acid derivative; proteinase inhibitor; pyrazine derivative; clinical trials; motor neuropathy; small vessel vasculitis; proteasome inhibitors; necrotizing arteritis
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 3
Issue: Suppl. 1
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2005-11-01
Start Page: S34
End Page: S36
Language: English
PUBMED: 16280110
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 24 October 2012" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz